Gracell Biotechnologies Inc - ADR
GRCL - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$172.05M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $172.05 Million |
|---|---|
| Enterprise Value | $-1,389,523,406.00 |
| Earnings per Share | $-44.85 |
| Beta | -0.35 |
| Outstanding Shares | 16,784,936 |
Return
| Return on Equity | -30.66% |
|---|---|
| Return on Assets | -26.30% |
| Return on Invested Capital | -34.86% |
Valuation & Multiples
| P/E Ratio | -1.52 |
|---|---|
| PEG | 2.5 |
| Price to Sales | - |
| Price to Book Ratio | 0.11 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 2.36 |
| Enterprise Value to Net Income | 2 |
| Total Debt to Enterprise | -0.08 |
| Debt to Equity | 0.07 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Gracell Biotechnologies Inc
2,020 employees
Gracell Biotechnologies Inc. (